Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP373596.RAi6Kb8frWNDF-CiBXK_BfqdNECIB3CK7640qh2_EzulU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP373596.RAi6Kb8frWNDF-CiBXK_BfqdNECIB3CK7640qh2_EzulU130_assertion type Assertion NP373596.RAi6Kb8frWNDF-CiBXK_BfqdNECIB3CK7640qh2_EzulU130_head.
- NP373596.RAi6Kb8frWNDF-CiBXK_BfqdNECIB3CK7640qh2_EzulU130_assertion description "[These data provide compelling evidence that 17-AAG may be effective in the treatment of c-kit-related diseases including mastocytosis, GISTs, mast cell leukemia, subtypes of acute myelogenous leukemia, and testicular cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP373596.RAi6Kb8frWNDF-CiBXK_BfqdNECIB3CK7640qh2_EzulU130_provenance.
- NP373596.RAi6Kb8frWNDF-CiBXK_BfqdNECIB3CK7640qh2_EzulU130_assertion evidence source_evidence_literature NP373596.RAi6Kb8frWNDF-CiBXK_BfqdNECIB3CK7640qh2_EzulU130_provenance.
- NP373596.RAi6Kb8frWNDF-CiBXK_BfqdNECIB3CK7640qh2_EzulU130_assertion SIO_000772 14551138 NP373596.RAi6Kb8frWNDF-CiBXK_BfqdNECIB3CK7640qh2_EzulU130_provenance.
- NP373596.RAi6Kb8frWNDF-CiBXK_BfqdNECIB3CK7640qh2_EzulU130_assertion wasDerivedFrom befree-20140225 NP373596.RAi6Kb8frWNDF-CiBXK_BfqdNECIB3CK7640qh2_EzulU130_provenance.
- NP373596.RAi6Kb8frWNDF-CiBXK_BfqdNECIB3CK7640qh2_EzulU130_assertion wasGeneratedBy ECO_0000203 NP373596.RAi6Kb8frWNDF-CiBXK_BfqdNECIB3CK7640qh2_EzulU130_provenance.